Table 1

Flow chart of the study

VisitScreening visit
(V0)
Baseline (V1)V2
(1 month±7 days)
V3
(3 months±7 days)
V4
(6 months±7 days)
V5
(9 months±15 days)
V6
(date of V5+7 days)
InformationX
Written consentX
Inclusion and non-inclusion criteriaX
Clinical assessmentXX
Vital signsXX
Anthropometric measuresXX
Blood samplesXX
PCDAI/PUCAI*XX
Bone ageXX
Bone mineral densityXX
Concomitant treatmentsXX
Quality of life/fatigue scoreXX
AE and SAE*XXXXX
RandomisationX
Physical activityXX
Dietary assessmentXX
Phone callXXXX
  • AE, adverse event; PCDAI, Pediatric Crohn’s Disease Activity Index; PUCAI, Pediatric Ulcerative Colitis Disease Activity Index; SAE, serious adverse event.